pH measurement in oral and nasal exhaled breath condensate in allergic rhinitic subjects Source: Eur Respir J 2003; 22: Suppl. 45, 447s Year: 2003
Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction Source: Eur Respir J 2004; 23: 559-564 Year: 2004
Comparison of the anti-inflammatory effects of extra-fine HFA-beclomethasone (BDP) versus fluticasone (FP)-DPI on inflammatory markers in exhaled breath in childhood asthma Source: Annual Congress 2007 - Childhood asthma: treatment and follow-up Year: 2007
A comparison of oral loratadine and fluticasone propionate aqueous nasal spray plus oral loratadine in the treatment of atopic cough associated with seasonal allergic rhinitis (SAR) Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005
Effect of montelukast added to inhaled steroids on exhaled NO in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 40s Year: 2001
Metabolomics applied to exhaled breath condensate in asthmatic children treated with inhaled steroids Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020
Effect of inhaled salmeterol or fluticasone on organic dust induced bronchial hyperreactivity Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002
Exhaled bronchial NO and cysteinyl-leukotrienes in breath condensate in atopic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Evaluation of fluticasone (flixonase) nasal spray versus beclomethasone (beconase) nasal spray in the treatment of allergic rhinitis Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
A comparison of the efficacy of beclomethasone dipropionate (BDP) and fluticasone propionate (FP) aqueous nasal spray on symptoms and quality of life in perennial allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 110s Year: 2003
Allergic rhinitis is associated with elevated adenosine level in exhaled breath condensate in nonasthmatic patients Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air Year: 2003
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge Source: Eur Respir J 2009; 33: 747-753 Year: 2009
Sustained reduction of bronchial hyperresponsiveness with inhaled fluticasone propionate in mild asthma within three days Source: Eur Respir J 2002; 20: Suppl. 38, 197s Year: 2002
Response to fluticasone propionate in controlling airway inflammation in steroid-naïve asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 317s Year: 2006
Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma Source: Eur Respir J 2002; 20: 853-858 Year: 2002
Exhaled hydrogen peroxide and airway hyperresponsiveness in nonasthmatic patients with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001
Leukotrienes and metabolites of nitric oxide in exhaled breath condensate of patients with allergic rhinitis in and out of pollen season Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003
The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation Source: Eur Respir J 2005; 26: Suppl. 49, 503s Year: 2005
Prostaglandin E2 in the expired breath condensate of patients with asthma Source: Eur Respir J 2003; 22: 743-747 Year: 2003
Acute effect of inhaled corticosteroid on exhaled breath temperature in asthmatic patients Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation Year: 2012